Effects of the SGLT2 Inhibitor Dapagliflozin on Cardiac Function Evaluated by Impedance Cardiography in Patients With Type 2 Diabetes. Secondary Analysis of a Randomized Placebo-Controlled Trial
Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0910-5
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2019
Authors
Publisher
Springer Science and Business Media LLC